Fifteen-year McKesson Corp. veteran Brian Tyler has been named the company’s executive vice president of corporate strategy and business development.


McKesson, Brian Tyler, executive vice president of corporate strategy and business development, Marc Owen, McKesson Specialty Health, John Hammergren, McKesson’s U.S. Pharmaceutical business, Geoff Walden








































































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Inside This Issue - News

McKesson’s Tyler gets bigger role

September 10th, 2012

SAN FRANCISCO – Fifteen-year McKesson Corp. veteran Brian Tyler has been named the company’s executive vice president of corporate strategy and business development.

He succeeds Marc Owen, who joined McKesson Specialty Health as president this year.

Tyler, who most recently served as president of McKesson’s U.S. Pharmaceutical business, will report to chairman and chief executive officer John Hammergren and become a member of the executive ­committee.

“With his deep understanding of the health care industry and relationships in the manufacturer, physician, hospital and pharmacy markets, Brian Tyler is exceptionally qualified to lead our corporate strategy and business development team,” Hammergren says. “His experience as president of [our] U.S. Pharmaceutical, Medical-Surgical and Specialty businesses provides a unique perspective on the challenges and opportunities facing our customers as health care reform drives further convergence throughout the industry.”

Tyler earlier served as senior vice president of strategy and business development for McKesson Distribution Solutions, with responsibility for strategic planning, joint ventures, alliances and other business development activities for the company’s pharmaceutical distribution, medical-surgical, health solutions and retail automation groups.

Prior to that he ran McKesson’s Specialty Care Solutions and Medical-Surgical businesses until assuming his most recent position as president of U.S. Pharmaceutical.

Advertisement